226 related articles for article (PubMed ID: 16237203)
1. Trends in predictors of death due to HIV-related causes among persons living with AIDS in New York City: 1993-2001.
Nash D; Katyal M; Shah S
J Urban Health; 2005 Dec; 82(4):584-600. PubMed ID: 16237203
[TBL] [Abstract][Full Text] [Related]
2. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
3. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
[TBL] [Abstract][Full Text] [Related]
4. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
[TBL] [Abstract][Full Text] [Related]
5. Implementation of named HIV reporting--New York City, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Jan; 52(51-52):1248-52. PubMed ID: 14704649
[TBL] [Abstract][Full Text] [Related]
6. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
7. Concurrent HIV/AIDS diagnosis increases the risk of short-term HIV-related death among persons newly diagnosed with AIDS, 2002-2005.
Hanna DB; Pfeiffer MR; Torian LV; Sackoff JE
AIDS Patient Care STDS; 2008 Jan; 22(1):17-28. PubMed ID: 18095838
[TBL] [Abstract][Full Text] [Related]
8. HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population.
Ormaasen V; Sandvik L; Dudman SG; Bruun JN
Scand J Infect Dis; 2007; 39(1):51-7. PubMed ID: 17366013
[TBL] [Abstract][Full Text] [Related]
9. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
[TBL] [Abstract][Full Text] [Related]
10. AIDS-defining opportunistic illnesses in the HAART era in New York City.
Hanna DB; Gupta LS; Jones LE; Thompson DM; Kellerman SE; Sackoff JE
AIDS Care; 2007 Feb; 19(2):264-72. PubMed ID: 17364409
[TBL] [Abstract][Full Text] [Related]
11. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy and declining AIDS mortality in New York City.
Messeri P; Lee G; Abramson DM; Aidala A; Chiasson MA; Jessop DJ
Med Care; 2003 Apr; 41(4):512-21. PubMed ID: 12665715
[TBL] [Abstract][Full Text] [Related]
13. Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment.
Palella FJ; Baker RK; Buchacz K; Chmiel JS; Tedaldi EM; Novak RM; Durham MD; Brooks JT;
AIDS; 2011 Sep; 25(15):1865-76. PubMed ID: 21811144
[TBL] [Abstract][Full Text] [Related]
14. The changing AIDS epidemic in New York City: a descriptive birth cohort analysis of AIDS incidence and age at diagnosis.
Fordyce EJ; Blum S; Shum R; Singh TP; Chiasson MA; Thomas P
AIDS; 1995 Jun; 9(6):605-10. PubMed ID: 7662200
[TBL] [Abstract][Full Text] [Related]
15. [Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].
Muga R; Egea JM; Navío M; Sirera G; Vall M; Tor J
Med Clin (Barc); 1999 May; 112(19):721-5. PubMed ID: 10394568
[TBL] [Abstract][Full Text] [Related]
16. Incident sexually transmitted infections among persons living with diagnosed HIV/AIDS in New York City, 2001-2002: a population-based assessment.
Manning SE; Pfeiffer MR; Nash D; Blank S; Sackoff J; Schillinger J
Sex Transm Dis; 2007 Dec; 34(12):1008-15. PubMed ID: 17621243
[TBL] [Abstract][Full Text] [Related]
17. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
[TBL] [Abstract][Full Text] [Related]
19. Race, sex, drug use, and progression of human immunodeficiency virus disease.
Chaisson RE; Keruly JC; Moore RD
N Engl J Med; 1995 Sep; 333(12):751-6. PubMed ID: 7643881
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
